Css LLC Il Purchases Shares of 9,900 Enovis Co. (NYSE:ENOV)

CSS LLC IL acquired a new position in Enovis Co. (NYSE:ENOV - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 9,900 shares of the company's stock, valued at approximately $434,000.

Other hedge funds have also recently made changes to their positions in the company. Paradigm Capital Management Inc. NY boosted its position in shares of Enovis by 2,566.0% during the fourth quarter. Paradigm Capital Management Inc. NY now owns 533,200 shares of the company's stock valued at $23,397,000 after purchasing an additional 513,200 shares in the last quarter. Woodline Partners LP boosted its stake in Enovis by 64.2% during the fourth quarter. Woodline Partners LP now owns 195,408 shares of the company's stock worth $8,575,000 after acquiring an additional 76,408 shares in the last quarter. Squarepoint Ops LLC grew its holdings in Enovis by 231.9% in the fourth quarter. Squarepoint Ops LLC now owns 157,006 shares of the company's stock worth $6,889,000 after purchasing an additional 109,707 shares during the period. Snowden Capital Advisors LLC bought a new position in shares of Enovis during the fourth quarter valued at approximately $219,000. Finally, Southeastern Asset Management Inc. TN boosted its position in shares of Enovis by 60.6% in the 4th quarter. Southeastern Asset Management Inc. TN now owns 36,583 shares of the company's stock worth $1,605,000 after purchasing an additional 13,797 shares in the last quarter. 98.45% of the stock is owned by hedge funds and other institutional investors.

Enovis Stock Performance

Shares of Enovis stock traded down $0.41 during trading on Wednesday, hitting $33.04. 165,769 shares of the company's stock traded hands, compared to its average volume of 786,103. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12. The business has a 50-day simple moving average of $34.45 and a 200-day simple moving average of $40.86. Enovis Co. has a 1 year low of $29.32 and a 1 year high of $51.00. The stock has a market capitalization of $1.89 billion, a P/E ratio of -15.08 and a beta of 1.79.

Enovis (NYSE:ENOV - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.81 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.07. The company had revenue of $558.83 million during the quarter, compared to analysts' expectations of $558.80 million. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. Enovis's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.50 earnings per share. As a group, analysts forecast that Enovis Co. will post 2.79 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ENOV. Needham & Company LLC reduced their price objective on Enovis from $64.00 to $57.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Canaccord Genuity Group cut their target price on Enovis from $75.00 to $70.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. Finally, JMP Securities lowered their price target on Enovis from $62.00 to $55.00 and set a "market outperform" rating for the company in a research report on Friday, May 9th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $58.00.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.